Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-α level and outcome)

American Journal of Cardiology

Volumn 93, Issue 10, 2004, Pages 1260-1264

  Gastmann, Anja ^b   Sigusch, Holger H ^a   Henke, Andreas ^b   Reinhardt, Dirk ^b   Surber, Ralf ^b   Gastmann, Oliver ^b   Figulla, Hans R ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CATALYSIS; CODON; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART TRANSPLANTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUTANT; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; SURVIVAL RATE; WILDLIFE;

AMP DEAMINASE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342542868     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.011     Document Type: Article

References (22)

1. Sabina R.L., Morisaki T., Clarke P., Eddy R., Shows T.B., Morton C.C., Holmes E.W. Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem. 265:1990;9423-9433
2. Morisaki T., Gross M., Morisaki H., Pongratz D., Zollner N., Holmes E.W. Molecular basis of AMP deaminase defiency in skeletal muscle. Proc Natl Acad Sci USA. 89:1992;6457-6461
3. Sabina R.L., Swain J.L., Olanow C.W., Bradley W.G., Fishbein W.N., Di M.S., Holmes E.W. Myoadenylate deaminase deficiency functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest. 73:1984;720-730
4. Reinstein L.J., Lichtman S.N., Currin R.T., Wang J., Thurman R.G., Lemasters J.J. Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine evidence for A2 receptors on rat Kupffer cells. Hepatology. 19:1994;1445-1452
5. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 76:1994;5-13
6. Wagner D.R., McTiernan C., Sanders V.J., Feldman A.M. Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-α in the failing human heart. Circulation. 97:1998;521-524
7. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241
8. Eichenholz P., Eichacker P.Q., Hoffman W.D., Banks S.M., Parillo J.E., Danner R.L., Natanson C. Tumor necrosis factor challenges in canines patterns of cardiovascular dysfunction. Am J Physiol. 263:1992;H668-H675
9. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., Mann D.L. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711
10. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., Mann D.L. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res. 81:1997;187-195
11. Loh E., Rebbeck T.R., Mahoney P.D., DeNofrio D., Swain J.L., Holmes E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation. 99:1999;1422-1425
12. Feldman A.M., Wagner D.R., McNamara D.M. AMPD1 gene mutation in congestive heart failure. New insights into the pathobiology of disease progression. Circulation. 99:1999;1397-1399
13. Sigusch H.H., Surber R., Lehmann M.H., Surber S., Weber J., Henke A., Reinhardt D., Hoffmann A., Figulla H.R. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scand J Clin Lab Invest. 60:2000;229-236
14. Gullestad L., Ueland T., Brunsvig A., Kjekshus J., Simonsen S., Frøland S.S., Aukrust P. Effect of metoprolol on cytokine levels in chronic heart failure - a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF). Am Heart J. 141:2001;418-421
15. Fuller R., Maxwell D., Conradson T., Dixon C.M., Barnes P.J. Circulatory and respiratory effects of infused adenosine in conscious man. Br J Clin Pharmacol. 24:1987;306-317
16. Hori M., Kitikaze M. Adenosine, the heart and coronary circulation. Hypertension. 18:1991;565-574
17. Downey J.M., Liu G.S., Thornton J.D. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res. 27:1993;3-8
18. Whittaker P., Kloner R.A., Przyklenk K. Intramyocardial injections and protection against myocardial ischemia an attempt to examine the cardioprotective actions of adenosine. Circulation. 93:1996;2043-2051
19. Toombs C.F., McGee D.S., Johnston W., Vinten-Johansen J. Myocardial protective effects of adenosine infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 86:1992;986-994
20. Kitikaze M., Hori M., Kamada T. The role of adenosine and its interactions with alpha-adrenoceptor activity in myocardial ischemic and reperfusion injury. Cardiovasc Res. 27:1993;18-27
21. Dubey R.K., Gillespie D.G., Mi Z., Ackson E.K. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts role of A2B receptors. Circulation. 96:1997;2656-2666
22. Anderson J.L., Habashi J., Carlquist J.F., Muhlestein J.B., Horne B.D., Baire T.L., Pearson R.R., Hart N. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary heart disease. J Am Coll Cardiol. 36:2000;1248-1252